非血管IVR（介入性放射線學）裝置的美國市場：2011年 是由出版商Millennium Research Group在2010年11月所出版的。
這份英文市場調查報告書價格從美金5995起跳。
2010年美國市場上非血管IVR裝置的收益規模些微低於2億3000萬美元。
本報告，提供美國非血管IVR裝置的市場整體，以及射頻燒灼裝置•冷凍療法裝置•經皮引流導管•軟組織切片針的市場概要與分析與競爭分析等，由下列摘要形式闡述。
報告摘要
調查方式
第1章 美國的非血管IVR裝置市場
第2章 射頻燒灼裝置市場
第3章 冷凍療法裝置市場
第4章 經皮引流導管市場
第5章 軟組織切片針市場
附錄
圖表一覽表
Abstract
The US market for nonvascular interventional radiology devices, comprising
disposable radiofrequency (RF) ablation and cryoablation devices for liver,
kidney, and lung cancer treatment, percutaneous drainage catheters, and soft
tissue biopsy needles, was valued at just under $230 million in 2010. Revenue
growth will be sustained primarily by the rising incidence of conditions for
which ablation devices, drainage catheters, and biopsy needles are used for
treatment or diagnosis - a trend supported by the aging US population - and
the increasing preference for minimally invasive procedures over the forecast
period. This will in turn be encouraged by the benefits of minimally invasive
techniques - including shorter recovery times and reduced patient
complications of surgery - and the release of clinical research supporting the
efficacy of these treatments. Although the strong presence of group purchasing
organizations (GPOs) will apply downward pressure on average selling prices
(ASPs), relatively few competitors are active in the US RF ablation and
cryoablation device segments, rendering them resistant to significant price
erosion. As a result, this market will experience rapid expansion through 2015.
METHODOLOGY
RESEARCH METHODOLOGY
This report uses a number of methodologies to gather and present data and
analysis. At the outset, a large survey of secondary sources is conducted.
These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include
- Government sources:
- Securities and Exchange Commission filings
- Food and Drug Administration and patent filings
- National Institutes of Health
- Professional Associations:
- American Association for the Study of Liver Diseases
- Nonvascular interventional radiology device companies:
- Annual reports, product brochures, corporate profiles, etc.
- Internal databases and reports:
- Previous reports on similar/related sources
- General Internet searches, medical literature, and newspaper/magazine
searches:
- Identifying various centers of specialization and articles that might
provide leads for primary research
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is either discarded or marked as high- or low-priority and then
organized appropriately as determined by the structure and sectioning of the
report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various nonvascular interventional
radiology device market segments. These assumptions are then used to determine
hypotheses using both inductive and deductive approaches. On the quantitative
front, these hypotheses result in full historical and projected market data
sets (market sizes - unit sales, average selling prices [ASPs], and revenues -
as well as market shares).
Step 3: At this stage, the research is in position for its most
important primary phase - expert interviews. Throughout the secondary research
phase, industry and medical experts are identified. These experts are then
contacted by telephone and asked to participate in interviews on recent trends
and developments in the industry. Interviews are either conducted at the time
of the initial call or scheduled at the convenience of the expert. Interview
questions are tailored to the expertise of each particular interviewee,
although in most cases, the most important questions are asked of all experts.
The questions are largely based on the assumptions and hypotheses developed in
Step 2, which are then augmented, discarded, or adjusted based on the views
and positions put forth. Attempts are made, whenever possible, to cross-check
the views of various experts against each other and to reach positions of
consensus on issues and market numbers.
In addition, a sample of interventional radiologists are interviewed via
telephone. These physicians are asked to comment on various issues/trends,
both in their own practice and in the overall market. The responses provided
are then used to strengthen or augment the assumptions and hypotheses
developed during the primary research phase.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group. All research results are assessed
and cross-checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and data points
finalized.
FORECAST METHODOLOGY
In addition to the research methodology outlined above, the following
“bottom-up” methodology is used to develop forecast assumptions
for the report.
A comprehensive breakdown of various nonvascular interventional radiology
procedures and unit sales is prepared using data from several sources,
including professional associations, government statistics, and private
research/media sources. Industry experts and practitioners are consulted to
ensure accuracy and verify observed trends. As a cross-check, total industry
revenues available through annual reports and other sources are compared
against modeled industry revenues. Using the best estimates of industry
experts, practitioners, private research/media sources, and inhouse experts,
year-by-year growth rates and ASPs are applied individually to each
subcategory to derive forecasts. These estimates are cross-checked by industry
experts (marketing managers, product managers, CEOs, etc.) and further refined.
Overall findings are compared against market and procedure forecasts published
by other sources to ensure reasonable estimates.
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
METHODOLOGY
1.0 US NONVASCULAR INTERVENTIONAL RADIOLOGY DEVICE MARKET
- 1.1 Market Overview
- 1.2 Market Analysis
- 1.2.1 Key Report Updates
- 1.2.2 Indication Overview
- 1.2.2.1 Kidney Cancer
- 1.2.2.2 Liver Cancer
- 1.2.2.3 Lung Cancer
- 1.2.3 Procedures
- 1.2.4 Market Forecast
- 1.3 Competitive Analysis
2.0 RADIOFREQUENCY ABLATION DEVICE MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Procedures
- 2.2.1.1 Kidney Cancer RF Ablation Procedures
- 2.2.1.2 Liver Cancer RF Ablation Procedures
- 2.2.1.3 Lung Cancer RF Ablation Procedures
- 2.2.2 Market Forecast
- 2.2.3 Market Drivers and Limiters
- 2.2.3.1 Market Drivers
- 2.2.3.2 Market Limiters
- 2.3 Competitive Analysis
- 2.3.1 Competitive Landscape
- 2.3.2 Market Shares
- 2.3.3 Competitor Discussions (in Alphabetical Order)
- 2.3.3.1 Leading Competitors
- AngioDynamics
- Boston Scientific
- Covidien
- 2.3.3.2 Emerging Competitors
- Celsion Corporation
- HS Medical
3.0 CRYOABLATION DEVICE MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Procedures
- 3.2.1.1 Kidney Cancer Cryoablation Procedures
- 3.2.1.2 Liver Cancer Cryoablation Procedures
- 3.2.1.3 Lung Cancer Cryoablation Procedures
- 3.2.2 Market Forecast
- 3.2.3 Market Drivers and Limiters
- 3.2.3.1 Market Drivers
- 3.2.3.2 Market Limiters
- 3.3 Competitive Analysis
- 3.3.1 Competitive Landscape
- 3.3.2 Market Shares
- 3.3.3 Competitor Discussions (in Alphabetical Order)
- Galil Medical
- HealthTronics (acquired by Endo Pharmaceuticals)
4.0 PERCUTANEOUS DRAINAGE CATHETER MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Procedures
- 4.2.2 Market Forecast
- 4.2.3 Market Drivers and Limiters
- 4.2.3.1 Market Drivers
- 4.2.3.2 Market Limiters
- 4.3 Competitive Analysis
- 4.3.1 Competitive Landscape
- 4.3.2 Market Shares
- 4.3.3 Competitor Discussions (in Alphabetical Order)
- AngioDynamics
- Angiotech
- Boston Scientific
- Cook Medical
- C. R. Bard
- Merit Medical Systems
- Teleflex Medical
- UreSil
5.0 SOFT TISSUE BIOPSY NEEDLE MARKET
- 5.1 Market Overview
- 5.2 Market Analysis
- 5.2.1 Procedures
- 5.2.2 Market Forecast
- 5.2.3 Market Drivers and Limiters
- 5.2.3.1 Market Drivers
- 5.2.3.2 Market Limiters
- 5.3 Competitive Analysis
- 5.3.1 Competitive Landscape
- 5.3.2 Competitor Discussions (in Alphabetical Order)
- Angiotech
- Boston Scientific
- Cardinal Health
- Cook Medical
- C. R. Bard
- Other
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: SUPPLEMENTAL FIGURES
LIST OF FIGURES AND TABLES
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
- Figure 1: Nonvascular Interventional Radiology Device Market, US (US$),
2009 - 2015
- Figure 2: RF Ablation Device Market, by Cancer Type, as a % of Total, US,
2010 and 2015
- Figure 3: Cryoablation Device Market, by Cancer Type, as a % of Total, US,
2010 and 2015
- Figure 4: Percutaneous Drainage Catheter Market, by Type, US (US$), 2009 -
2015
- Figure 5: Soft Tissue Biopsy Needle Market, by Segment, US (US$), 2009 -
2015
- Table 1: Companies Mentioned in This Report
METHODOLOGY
1.0 US NONVASCULAR INTERVENTIONAL RADIOLOGY DEVICE MARKET
- Figure 6: Nonvascular Interventional Radiology Device Market, by Segment,
US (US$), 2009 - 2015
- Table 2: Key Report Updates, 2011
- Table 3 Incidence of Primary-Origin Renal Cell Carcinoma, by Tumor Status,
US, 2009 - 2015
- Table 4 Incidence of Primary-Origin Hepatocellular Carcinoma, by Tumor
Status, US, 2009 - 2015
- Table 5 Incidence of Primary-Origin Non-Small-Cell Lung Cancer, by Tumor
Status, US, 2009 - 2015
- Table 6: Nonvascular Interventional Radiology Procedures, by Segment, US,
2009 - 2015
- Table 7: Nonvascular Interventional Radiology Device Market, by Segment,
US (US$), 2009 - 2015
- Table 8: Competitors in the Nonvascular Interventional Radiology Device
Market, US, 2010
2.0 RADIOFREQUENCY ABLATION DEVICE MARKET
- Figure 7: RF Ablation Device Market, by Cancer Type, US (US$), 2009 - 2015
- Table 9: RF Ablation Procedures, by Cancer Type, US, 2009 - 2015
- Table 10: Kidney Cancer RF Ablation Procedures, by Origin of Cancer, US,
2009 - 2015
- Table 11: Liver Cancer RF Ablation Procedures, by Origin of Cancer, US,
2009 - 2015
- Table 12: Lung Cancer RF Ablation Procedures, by Origin of Cancer, US,
2009 - 2015
- Table 13: RF Ablation Device Market, by Cancer Type, US (US$), 2009 - 2015
- Table 14: RF Ablation Device Market Growth, by Cancer Type, US, 2010 - 2015
- Table 15: RF Ablation Device Market, by Cancer Type, as a % of Total, US,
2009 - 2015
- Table 16: Kidney Cancer RF Ablation Device Market, by Origin of Cancer, US
(US$), 2009 - 2015
- Table 17: Liver Cancer RF Ablation Device Market, by Origin of Cancer, US
(US$), 2009 - 2015
- Table 18: Lung Cancer RF Ablation Device Market, by Origin of Cancer, US
(US$), 2009 - 2015
- Table 19: Drivers and Limiters of the RF Ablation Device Market, US
- Table 20: Leading Competitors in the RF Ablation Device Market, as a % of
Total, US, 2010
3.0 CRYOABLATION DEVICE MARKET
- Figure 8: Cryoablation Device Market, by Cancer Type, US (US$), 2009 - 2015
- Table 21: Cryoablation Procedures, by Cancer Type, US, 2009 - 2015
- Table 22: Kidney Cancer Cryoablation Procedures, by Origin of Cancer, US,
2009 - 2015
- Table 23: Liver Cancer Cryoablation Procedures, by Origin of Cancer, US,
2009 - 2015
- Table 24: Lung Cancer Cryoablation Procedures, by Origin of Cancer, US,
2009 - 2015
- Table 25: Cryoablation Device Market, by Cancer Type, US (US$), 2009 - 2015
- Table 26: Cryoablation Device Market Growth, by Cancer Type, US, 2010 -
2015
- Table 27: Cryoablation Device Market, by Cancer Type, as a % of Total, US,
2009 - 2015
- Table 28: Kidney Cryoablation Device Market, by Origin of Cancer, US
(US$), 2009 - 2015
- Table 29: Liver Cryoablation Device Market, by Origin of Cancer, US (US$),
2009 - 2015
- Table 30: Lung Cryoablation Device Market, by Origin of Cancer, US (US$),
2009 - 2015
- Table 31: Drivers and Limiters of the Cryoablation Device Market, US
- Table 32: Leading Competitors in the Cryoablation Device Market, as a % of
Total, US, 2010
4.0 PERCUTANEOUS DRAINAGE CATHETER MARKET
- Figure 9: Percutaneous Drainage Catheter Market, by Type, US (US$), 2009 -
2015
- Table 33: Percutaneous Drainage Catheter Procedures, by Type, US, 2009 -
2015
- Table 34: Percutaneous Drainage Catheter Market, by Type, US (US$), 2009 -
2015
- Table 35: Percutaneous Drainage Catheter Market Growth, by Type, US, 2010
- 2015
- Table 36: Percutaneous Drainage Catheter Market, by Type, as a % of Total,
US, 2009 - 2015
- Table 37: Drivers and Limiters of the Percutaneous Drainage Catheter
Market, US
- Table 38: Leading Competitors in the Drainage Catheter Market, as a % of
Total, US, 2010
5.0 SOFT TISSUE BIOPSY NEEDLE MARKET
- Figure 10: Soft Tissue Biopsy Needle Market, by Segment, US (US$), 2009 -
2015
- Table 39: Soft Tissue Biopsy Needle Procedures, by Type, US, 2009 - 2015
- Table 40: Soft Tissue Biopsy Needle Market, by Segment, US (US$), 2009 -
2015
- Table 41: Soft Tissue Biopsy Needle Market Growth, by Segment, US, 2010 -
2015
- Table 42: Soft Tissue Biopsy Needle Market, by Segment, as a % of Total,
US, 2009 - 2015
- Table 43: Drivers and Limiters of the Soft Tissue Biopsy Needle Market, US
APPENDIX A: MRG ACRONYMS AND INITIALISMS
- MRG Acronyms and Initialisms
APPENDIX B: SUPPLEMENTAL FIGURES
- Figure 11: Nonvascular Interventional Radiology Device Market, US (US$),
2009 - 2015 (Detailed Format)
- Figure 12: RF Ablation Device Market, by Cancer Type, as a % of Total, US,
2010 and 2015 (Detailed Format)
- Figure 13: Cryoablation Device Market, by Cancer Type, as a % of Total,
US, 2010 and 2015 (Detailed Format)
- Figure 14: Percutaneous Drainage Catheter Market, by Type, US (US$), 2009
- 2015 (Detailed Format)
- Figure 15: Soft Tissue Biopsy Needle Market, by Segment, US (US$), 2009 -
2015 (Detailed Format)
|
